GE HealthCare misses quarterly revenue estimates on weakness in China market
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/6/2026
- S&P 500, Nasdaq close sharply higher as Broadcom rallies
- Oil prices settle at pre-Iran war levels as crude output grows
- Broadcom stock pops 4% as Apple silicon deal gets extended through 2031
- Buy the pullback in chip stocks, JPM's Matejka says
- Memory stocks rebound as analysts flag a buying opportunity
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Dara Khosrowshahi steps down from Grab Holdings board
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- Broadcom secures role as key Apple supplier with chip deal through 2031
- S&P 500, Nasdaq close sharply higher as Broadcom rallies
BofA thinks the selloff in GE HealthCare (GEHC) may be overdone. Here's why
May 1, 2024 12:30 PM EDTFollowing a surprising miss in revenue and earnings per share (EPS) for the first quarter, shares of GE HealthCare (NASDAQ: GEHC) experienced a significant downturn, plummeting over 14% on Tuesday. The miss, which caught investors off guard, was driven by unexpected disruptions in China and a more pronounced second half ramp.
Despite the... More
GE HealthCare (GEHC) PT Lowered to $96 at Evercore ISI
April 30, 2024 12:05 PM EDTEvercore ISI analyst Vijay Kumar lowered the price target on GE HealthCare (NASDAQ: GEHC) to $96.00 (from $100.00) while maintaining a Outperform rating.
The analyst comments "GEHC reported org rev declines of -50 bps, with revs of $4.65 Bn coming in ~150M or 3% below ST. The miss was mainly driven by lower capital sales (MRI, CT, ultrasound & monitoring/vents) and was partly offset by better PDx. Geographically, the miss was driven by China as customers paused due to stimulus announcement. 1Q also had some order fulfillment issues in its PCS segment. On the positive side, GMs were up... More
